| LINE ITEM (USD / %) | FY 2025
FILED 2025-10-03 | FY 2024
FILED 2024-09-27 | FY 2023
FILED 2023-09-29 |
|---|---|---|---|
| Revenue (Total Sales) | $14.39B | $8.39B | $7.87B |
| YoY Revenue Growth % | +71.6% | +6.6% | — |
| Gross Profit | $1.51B | $798.0M | — |
| Gross Margin % | 10.5% | 9.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $480.0M | $291.0M | $57.0M |
| Operating Margin % | 3.3% | 3.5% | 0.7% |
| Net Income (GAAP) | $66.0M | -$82.0M | -$314.0M |
| EBITDA (Normalized) | $501.6M | $299.8M | $340.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $543.0M | $47.0M | $67.0M |
| Capital Expenditures (CapEx) | $27.0M | $11.0M | $353.9M |
| Free Cash Flow (FCF) | $516.0M | $36.0M | -$286.9M |
| FCF Margin % | 3.6% | 0.4% | -3.6% |
| Return on Invested Capital (ROIC %) | 4.6% | 2.7% | 0.8% |
| Cash & Short-Term Equivalents | $247.0M | $522.0M | — |
| Total Debt (Short + Long Term) | $3.89B | $4.64B | $2.21B |
| Total Stockholders' Equity | $4.56B | $4.47B | $4.53B |